Economic impact of adopting pemetrexed plus cisplatin for malignant pleural mesothelioma into Scottish clinical practice

被引：0
|
作者：
Chetty, M
Cordony, A
Davey, P
Karampela, K
Le Reun, C
Watt, M
机构：
[1] MTAG Pty Ltd, Chatswood, NSW, Australia
[2] Eli Lilly & Co, Basingstoke, Hants, England
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67239-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A33 / A33
页数：1
相关论文
共 50 条
  • [1] Economic impact of adopting pemetrexed plus cisplatin for malignant pleural mesothelioma into Scottish clinical practice
    Chetty, M.
    Cordony, A.
    Davey, P.
    Karampela, K.
    Symanowski, J.
    Le Reun, C.
    Watt, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 329 - 329
  • [2] Cost-effectiveness of pemetrexed plus cisplatin: Malignant pleural mesothelioma treatment in UK clinical practice
    Cordony, Anna
    Le Reun, Corinne
    Smala, Antje
    Symanowski, James T.
    Watkins, Jessamy
    VALUE IN HEALTH, 2008, 11 (01) : 4 - 12
  • [3] Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma
    Hasegawa, Seiki
    Yokoi, Kohei
    Okada, Morihito
    Tanaka, Fumihiro
    Shimokawa, Mototsugu
    Daimon, Takashi
    Nakano, Takashi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (06): : 1940 - +
  • [4] Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients
    Shukuya, Takehito
    Takahashi, Toshiaki
    Imai, Hisao
    Tokito, Takaaki
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Yamamoto, Nobuyuki
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 101 - 106
  • [5] Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma
    Woods, Beth
    Paracha, Noman
    Scott, David A.
    Thatcher, Nicholas
    LUNG CANCER, 2012, 75 (02) : 261 - 267
  • [6] Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma - Czech Experience
    Kolek, Vitezslav
    Havel, Libor
    Pesek, Milos
    Salajka, Frantisek
    Koubkova, Leona
    Roubec, Jaromir
    Skrickova, Jana
    Sixtova, Dimka
    Hejduk, Karel
    Bortlicek, Zbynek
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S747 - S747
  • [7] Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed
    Hidetoshi Hayashi
    Isamu Okamoto
    Yasuko Ichikawa
    Masaki Miyazaki
    Hiroshige Yoshioka
    Kei Kunimasa
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2010, 15 : 497 - 499
  • [8] RETREATMENT OF RECURRENT MALIGNANT PLEURAL MESOTHELIOMA WITH CISPLATIN AND PEMETREXED
    Hayashi, Hidetoshi
    Okamoto, Isamu
    Miyazaki, Masaki
    Ichikawa, Yasuko
    Yoshioka, Hiroshige
    Kunimasa, Kei
    Tanaka, Kaoru
    Okamoto, Kunio
    Makimura, Chihiro
    Iwasaku, Masahiro
    Nisiyama, Akihiro
    Korogi, Yohhei
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [9] Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed
    Hayashi, Hidetoshi
    Okamoto, Isamu
    Ichikawa, Yasuko
    Miyazaki, Masaki
    Yoshioka, Hiroshige
    Kunimasa, Kei
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 497 - 499
  • [10] Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
    Pasello, Giulia
    Marulli, Giuseppe
    Polo, Valentina
    Breda, Cristiano
    Bonanno, Laura
    Loreggian, Lucio
    Rea, Federico
    Favaretto, Adolfo
    ANTICANCER RESEARCH, 2012, 32 (12) : 5393 - 5399
12345